1,044
Views
0
CrossRef citations to date
0
Altmetric
Research article

Analysis of clinical characteristics and treatment efficacy in two pediatric cases of ANKRD26-related thrombocytopenia

, , &
Article: 2262607 | Received 11 Aug 2022, Accepted 19 Sep 2023, Published online: 18 Oct 2023

References

  • Pippucci T, Savoia A, Perrotta S, Pujol-Moix N, Noris P, Castegnaro G, Pecci A, Gnan C, Punzo F, Marconi C, et al. Mutations in the 5′ UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2. Am JHum Genet. 2011;88:115–7. doi:10.1016/j.ajhg.2010.12.006.
  • Savoia A, Del Vecchio M, Totaro A, Perrotta S, Amendola G, Moretti A, Zelante L, Iolascon A. An autosomal dominant thrombocytopenia gene maps to chromosomal region 10p. Am J Hum Genet. 1999;65(5):1401–5. doi:10.1086/302637.
  • Drachman JG, Jarvik GP, Mehaffey MG. Autosomal dominant thrombocytopenia: incomplete megakaryocyte differentiation and linkage to human chromosome 10. Blood. 2000;96(1):118–25. doi:10.1182/blood.V96.1.118.
  • Fiore M, Saut N, Alessi MC, Viallard JF. Successful use of eltrombopag for surgical preparation in a patient with ANKRD26-related thrombocytopenia. Platelets. 2016;27(8):828–9. doi:10.1080/09537104.2016.1190446.
  • Zaninetti C, Gresele P, Bertomoro A, Klersy C, De Candia E, Veneri D, Barozzi S, Fierro T, Alberelli MA, Musella V, et al. Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial. Haematologica. 2020;105(3):820–8. doi:10.3324/haematol.2019.223966.
  • Fogarty PF, Tarantino MD, Signorovitch J, Grotzinger KM. Selective validation of the WHO bleeding scale in patients with chronic immune thrombocytopenia. Curr Med Res Opin. 2012;28:79–87. doi:10.1185/03007995.2011.644849.
  • Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA, American Society of Hematology. The American society of hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190–207. doi:10.1182/blood-2010-08-302984.
  • NCI. National cancer institute common terminology criteria for adverse events (CTCAE) v5.0. [Accessed 2018 Nov 8]. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm.2017.
  • Ferrari S, Lombardi AM, Putti MC. Spectrum of 5‘UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected. Platelets. 2017;28:621–4. doi:10.1080/09537104.2016.1267337.
  • Boutroux H, Petit A, Auvrignon A, Lapillonne H, Ballerini P, Favier R, Leverger G. Childhood diagnosis of genetic thrombocytopenia with mutation in the ankyrine repeat domain 26 gene. EurJPediatr. 2015;174(10):1399–403. doi:10.1007/s00431-015-2549-x.
  • Noris P, Perrotta S, Seri M, Pecci A, Gnan C, Loffredo G, Pujol-Moix N, Zecca M, Scognamiglio F, De Rocco D, et al. Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood. 2011;117(24):6673–80. doi:10.1182/blood-2011-02-336537.
  • Noris P, Pecci A. Hereditary thrombocytopenias: a growing list of disorders. Hematology Am Soc Hematol Educ Program. 2017;2017(1):385–99. doi:10.1182/asheducation-2017.1.385.
  • Zaninetti C, Santini V, Tiniakou M, Barozzi S, Savoia A, Pecci A. Inherited thrombocytopenia caused by ANKRD26 mutations misdiagnosed and treated as myelodysplastic syndrome: report on two cases. J Thromb Haemost. 2017;15(12):2388–92. doi:10.1111/jth.13855.
  • Perez BJ, Dugan SN, Anderson MW. ANKRD26-related thrombocytopenia. In: Adam M, Mirzaa G, Pagon R, Wallace S, Bean L, Gripp K Amemiya A, editors. GeneReviews®[Internet]. Seattle (WA): University of Washington; 2018. p. 1993–2022.
  • Hahn Y, Bera TK, Pastan IH, Lee B. Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domains. Gene. 2006;366(2):238–45. doi:10.1016/j.gene.2005.07.045.
  • Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, Steward M, Burns P, Langford CF, Ellis PD, Dudbridge F, Zwaginga JJ, et al. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood. 2007;109(8):3260–9. doi:10.1182/blood-2006-07-036269.
  • Bluteau D, Balduini A, Balayn N, Currao M, Nurden P, Deswarte C, Leverger G, Noris P, Perrotta S, Solary E, et al. Thrombocytopenia associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation. J Clin Invest. 2014;124(2):580–91. doi:10.1172/JCI71861.
  • Balduini A, Raslova H, Di Buduo CA, Donada A, Ballmaier M, Germeshausen M, Balduini CL. Clinic, pathogenic mechanisms and drug testing of two inherited thrombocytopenias, ANKRD26-related thrombocytopenia and MYH9-related diseases. Eur J Med Genet. 2018;61(11):715–22. doi:10.1016/j.ejmg.2018.01.014.
  • Noris P, Favier R, Alessi MC, Geddis AE, Kunishima S, Heller PG, Giordano P, Niederhoffer KY, Bussel JB, Podda GM, et al. ANKRD26-related thrombocytopenia and myeloid malignancies. Blood. 2013;122(11):1987–9. doi:10.1182/blood-2013-04-499319.
  • Diep RT, Corey K, Arcasoy MO. A novel nucleotide substitution in the 5′untranslated region of ANKRD26 gene is associated with inherited thrombocytopenia: a report of two new families. Ann Hematol. 2019;98(7):1789–91. doi:10.1007/s00277-019-03632-y.
  • Ventz R, Hundemer M, Witzens-Harig M, Lehmann B, Felbor U, Najm J. Mild bleeding diathesis in a 62-year-old woman with hereditary thrombocytopenia. Internist (Berl). 2013;54(6):765–8. doi:10.1007/s00108-013-3284-x.
  • Guison J, Blaison G, Stoica O, Hurstel R, Favier M, Favier R. Idiopathic pulmonary embolism in a case of severe family ANKRD26thrombocytopenia. Mediterr J Hematol Infect Dis. 2017;9(1):e2017038. doi:10.4084/mjhid.2017.038.
  • Averina M, Jensvoll H, Strand H, Sovershaev M. A novel ANKRD26 gene variant causing inherited thrombocytopenia in a family of Finnish origin: another brick in the wall? Thromb Res. 2017;151:41–3. doi:10.1016/j.thromres.2017.01.001.
  • Fournier E, Debord C, Soenen V, Sovershaev M. Baseline dysmegakaryopoiesis in inherited thrombocytopenia/platelet disorder with predisposition to haematological malignancies. Br J Haematol. 2020;189(4):e119–e22. doi:10.1111/bjh.16543.
  • Tan C, Dai L, Chen Z, Yang W, Wang Y, Zeng C, Xiang Z, Wang X, Zhang X, Ran Q, et al. A rare big Chinese family with thrombocytopenia 2: a case report and literature review. Front Genet. 2020;11:340. doi:10.3389/fgene.2020.00340.
  • Zidan NI, AbdElmonem DM, Elsheikh HM, Metwally EA, Mokhtar WA, Osman GM. Relation between mutations in the 5’ UTR of ANKRD26 gene and inherited thrombocytopenia with predisposition to myeloid malignancies. An Egyptian study. Platelets. 2021;32:642–50. doi:10.1080/09537104.2020.1790512.
  • Al Daama SA, Housawi YH, Dridi W, Sager M, Otieno FG, Hou C, Vasquez L, Kim C, Tian L, Sleiman P, et al. A missense mutation in ANKRD26 segregates with thrombocytopenia. Blood. 2013;122(3):461–2. doi:10.1182/blood-2013-03-489344.